PL3023410T3 - Sole sodowe kwasu 5-bromo-2-(alfa-hydroksypentylo)benzoesowego w różnych postaciach krystalicznych i sposób ich wytwarzania - Google Patents

Sole sodowe kwasu 5-bromo-2-(alfa-hydroksypentylo)benzoesowego w różnych postaciach krystalicznych i sposób ich wytwarzania

Info

Publication number
PL3023410T3
PL3023410T3 PL14826150T PL14826150T PL3023410T3 PL 3023410 T3 PL3023410 T3 PL 3023410T3 PL 14826150 T PL14826150 T PL 14826150T PL 14826150 T PL14826150 T PL 14826150T PL 3023410 T3 PL3023410 T3 PL 3023410T3
Authority
PL
Poland
Prior art keywords
hydroxypentyl
bromine
alpha
preparation
benzoic acid
Prior art date
Application number
PL14826150T
Other languages
English (en)
Inventor
Junbiao Chang
Chuanjun SONG
Original Assignee
Zhejiang Ausun Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Ausun Pharmaceutical Co., Ltd. filed Critical Zhejiang Ausun Pharmaceutical Co., Ltd.
Publication of PL3023410T3 publication Critical patent/PL3023410T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/68Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
    • C07C63/70Monocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/43Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58Preparation of carboxylic acid halides
    • C07C51/60Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL14826150T 2013-07-17 2014-07-10 Sole sodowe kwasu 5-bromo-2-(alfa-hydroksypentylo)benzoesowego w różnych postaciach krystalicznych i sposób ich wytwarzania PL3023410T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201310299084 2013-07-17
CN201410313214.4A CN104086399B (zh) 2013-07-17 2014-07-03 5-溴-2-(α-羟基戊基)苯甲酸钠盐的不同晶型及其制备方法
EP14826150.6A EP3023410B1 (en) 2013-07-17 2014-07-10 5-BROMINE-2-(alpha-HYDROXYPENTYL)BENZOIC ACID SODIUM SALTS IN DIFFERENT CRYSTAL FORMS, AND PREPARATION METHOD THEREOF
PCT/CN2014/081954 WO2015007181A1 (zh) 2013-07-17 2014-07-10 5-溴-2-(α-羟基戊基)苯甲酸钠盐的不同晶型及其制备方法

Publications (1)

Publication Number Publication Date
PL3023410T3 true PL3023410T3 (pl) 2022-06-06

Family

ID=51634190

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14826150T PL3023410T3 (pl) 2013-07-17 2014-07-10 Sole sodowe kwasu 5-bromo-2-(alfa-hydroksypentylo)benzoesowego w różnych postaciach krystalicznych i sposób ich wytwarzania

Country Status (16)

Country Link
US (4) US9902682B2 (pl)
EP (1) EP3023410B1 (pl)
JP (1) JP6483674B2 (pl)
KR (2) KR102279371B1 (pl)
CN (2) CN104086399B (pl)
DK (1) DK3023410T3 (pl)
ES (1) ES2913338T3 (pl)
HR (1) HRP20220665T1 (pl)
HU (1) HUE058690T2 (pl)
LT (1) LT3023410T (pl)
PL (1) PL3023410T3 (pl)
PT (1) PT3023410T (pl)
RS (1) RS63249B1 (pl)
RU (2) RU2738374C1 (pl)
SI (1) SI3023410T1 (pl)
WO (1) WO2015007181A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104086399B (zh) * 2013-07-17 2016-08-24 浙江奥翔药业股份有限公司 5-溴-2-(α-羟基戊基)苯甲酸钠盐的不同晶型及其制备方法
WO2018126897A1 (zh) * 2017-01-06 2018-07-12 郑州大学 5-溴-2-(α-羟基戊基)苯甲酸钠在治疗心血管疾病药物中的应用
PT3845524T (pt) * 2018-03-19 2022-09-28 Henan Genuine Biotech Co Ltd Compostos de ácido benzoico e método de preparação destes e suas aplicações
CN108715579B (zh) 2018-05-17 2020-03-24 四川大学 一种2-(α羟基戊基)苯甲酸的有机胺酯衍生物药物
CN109223749A (zh) * 2018-11-14 2019-01-18 郑州大学 5- 溴-2-(α- 羟基戊基)苯甲酸钠盐在治疗心肌肥厚和心力衰竭中的药物用途
CN111943898A (zh) * 2019-05-17 2020-11-17 浙江大学 苯联四氮唑类衍生物、制备、含其的药物组合物及其应用
WO2021185356A1 (zh) 2020-03-20 2021-09-23 石药集团恩必普药业有限公司 丁基苯酞及其衍生物的用途
WO2022089544A1 (zh) * 2020-10-30 2022-05-05 浙江奥翔药业股份有限公司 Bzp在治疗心脑缺血性疾病中的应用
CN112457265A (zh) * 2020-11-06 2021-03-09 浙江大学 四氮唑类衍生物、制备、含其的药物组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2305092C2 (ru) * 2002-05-09 2007-08-27 Инститьют Оф Материя Медика, Чайниз Экедеми Оф Медикал Сайенсез НОВЫЕ 2-(α-ГИДРОКСИПЕНТИЛ)БЕНЗОАТЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ
CN1243541C (zh) 2002-05-09 2006-03-01 中国医学科学院药物研究所 2-(α-羟基戊基)苯甲酸盐及其制法和用途
CN100422133C (zh) * 2003-09-01 2008-10-01 北京天衡药物研究院 2-(α-羟基戊基)苯甲酸盐及其制法和用途
CN100540523C (zh) * 2004-06-17 2009-09-16 北京天衡药物研究院 L-2-(α-羟基戊基)苯甲酸盐及其制法和用途
CN101054346A (zh) * 2006-04-13 2007-10-17 温建波 一组新化合物及其组合物的制备方法和用途
CN100554259C (zh) 2007-04-12 2009-10-28 郑州大学 2-苯并[c]呋喃酮化合物及其应用
CN101402565B (zh) * 2008-11-14 2012-07-04 郑州大学 卤代2-(a-羟基戊基)苯甲酸盐及其制法和用途
CN103113210A (zh) * 2013-02-19 2013-05-22 石药集团中奇制药技术(石家庄)有限公司 羟戊基苯甲酸钾晶体及其制备方法
CN104086399B (zh) * 2013-07-17 2016-08-24 浙江奥翔药业股份有限公司 5-溴-2-(α-羟基戊基)苯甲酸钠盐的不同晶型及其制备方法

Also Published As

Publication number Publication date
CN104086399A (zh) 2014-10-08
US20160168069A1 (en) 2016-06-16
RU2016101132A (ru) 2017-08-22
HRP20220665T1 (hr) 2022-06-24
DK3023410T3 (da) 2022-05-23
CN104086399B (zh) 2016-08-24
US10377693B2 (en) 2019-08-13
PT3023410T (pt) 2022-06-28
US11148991B2 (en) 2021-10-19
CN105517988B (zh) 2017-04-12
KR20160031004A (ko) 2016-03-21
WO2015007181A1 (zh) 2015-01-22
KR102279367B1 (ko) 2021-07-20
RS63249B1 (sr) 2022-06-30
RU2738374C1 (ru) 2020-12-11
JP6483674B2 (ja) 2019-03-13
EP3023410A4 (en) 2017-02-08
KR20210035336A (ko) 2021-03-31
CN105517988A (zh) 2016-04-20
EP3023410B1 (en) 2022-02-23
ES2913338T3 (es) 2022-06-01
LT3023410T (lt) 2022-09-12
US20180127349A1 (en) 2018-05-10
HUE058690T2 (hu) 2022-09-28
EP3023410A1 (en) 2016-05-25
US20190194116A1 (en) 2019-06-27
JP2016528210A (ja) 2016-09-15
US10604471B2 (en) 2020-03-31
KR102279371B1 (ko) 2021-07-20
SI3023410T1 (sl) 2022-06-30
US9902682B2 (en) 2018-02-27
RU2643802C2 (ru) 2018-02-06
US20190315673A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
HUE058690T2 (hu) 5-bróm-2-(alfa-hidroxipentil)benzoesav-nátriumsók különbözõ kristályformákban és eljárás ezek elõállítására
EP2941246A4 (en) BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USES
ZA201508948B (en) Phenol derivative and preparation method and use in medicine thereof
BR302012000450S1 (pt) Configuração aplicada em cápsula.
HK1225372A1 (zh) 氨基酸衍生物
EP2898903A4 (en) HIGHLY HYGOSCOPIC WOUND BAND AND METHOD OF MANUFACTURE AND USE THEREOF
ZA201506298B (en) Fertilizer composition and method for suspending fertilizer in an aqueous solution
HK1218709A1 (zh) 新水楊酸衍生物、其藥學上可接受的鹽、其組合物以及其使用方法
SG11201602533QA (en) Three-pack type dialysis agent containing acetic acid and acetic acid salt
SG2013073051A (en) Iodine-based etching solution and etching method
EP2938607A4 (en) CRYSTALLINE SALTS AND FORMS
HK1219895A1 (zh) 種增加脊柱側凸受試者的細胞中的 信號傳導作用的方法
EP2865666A4 (en) HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE
EP2805956A4 (en) GAMBOGIC ACID DERIVATIVES, PREPARATION METHOD AND APPLICATION THEREOF
HK1220627A1 (zh) 氯苯那敏或其鹽的穩定化方法
EP2825614A4 (en) TREATMENT FLUIDS WITH A HYDROXYPYRIDINE CARBOXYLIC ACID AND METHOD OF USE THEREOF
PL2998305T3 (pl) Kryształ soli trilitowej chinonu pirolochinoliny, sposób jego otrzymywania i zastosowanie
EP2996575A4 (en) Aerostasis in pulmonary surgery
IL240447A0 (en) Propionic-biaryl acid derivatives and their use as pharmaceutical preparations
EP3000807A4 (en) Mercaptonicotinic acid compound and preparation method and use thereof
IL240422B (en) Bi-aryl derivatives of propionic acid and their use as medicinal preparations
IL244246B (en) Multivalent sialic acid derivatives
EP3050893A4 (en) Glycoamino acid and use thereof
BR302012006677S1 (pt) Configuração aplicada em ralo
BR302013006079S1 (pt) Configuração aplicada em espátula